Genprex, Inc.
(NASDAQ : GNPX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
2.33%43.120.9%$1175.90m
LLYEli Lilly and Company
1.61%124.691.0%$1059.07m
JNJJohnson & Johnson
0.69%136.360.6%$990.16m
MRKMerck & Co., Inc.
1.15%80.750.6%$959.29m
BMYBristol-Myers Squibb Company
1.58%50.921.4%$781.20m
ABBVAbbVie, Inc.
1.26%79.742.2%$664.75m
AZNAstraZeneca PLC Sponsored ADR
0.89%40.791.3%$194.88m
NVSNovartis AG Sponsored ADR
0.27%90.750.2%$187.39m
GSKGlaxoSmithKline plc Sponsored ADR
-0.15%40.480.2%$136.37m
NVONovo Nordisk A/S Sponsored ADR Class B
0.20%49.760.1%$70.36m
SNYSanofi Sponsored ADR
-0.34%41.190.2%$36.73m
LCILannett Company, Inc.
2.25%9.5636.7%$16.79m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.54%1.841.7%$0.06m
EPIXESSA Pharma Inc
5.13%3.750.1%$0.05m

Company Profile

Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.